CG Oncology (CGON) Operating Leases (2023 - 2026)
CG Oncology's (CGON) quarterly Operating Leases came in at $3.5 million in Q1 2026, up 349.3% YoY from $781000.0 in Q1 2025, and up 12.97% on a QoQ basis from $3.1 million in Q4 2025.
CG Oncology (CGON) Operating Leases (2023 - 2026) Analysis & Trends
CG Oncology (CGON) has 4 years of Operating Leases data on file, last reported at $3.5 million in Q1 2026.
- Quarterly Operating Leases rose 349.3% year-over-year to $3.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.5 million (up 349.3% YoY) and the FY2025 annual result came in at $3.1 million, up 5873.08% from the prior year.
- Operating Leases climbed to $3.5 million in Q1 2026, from $3.1 million in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $3.5 million in Q1 2026 to a low of $52000.0 in Q4 2024.
- A 4-year average of $1.2 million and a median of $475000.0 in 2023 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2024 — Operating Leases slumped 78.69% — and 2025, when it soared 5873.08%.
- Tracing CGON's Operating Leases over 4 years: stood at $244000.0 in 2023, then tumbled by 78.69% to $52000.0 in 2024, then soared by 5873.08% to $3.1 million in 2025, then grew by 12.97% to $3.5 million in 2026.
- The last three Operating Leases figures came in at $3.5 million (Q1 2026), $3.1 million (Q4 2025), and $3.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | CG Oncology | 6.63 Bn | 6.63 Bn | -2.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.83 Mn |
| Mar 31, 2026 | 3.51 Mn |
| Dec 31, 2025 | 3.11 Mn |
| Sep 30, 2025 | 3.33 Mn |
| Jun 30, 2025 | 706,000.00 |
| Mar 31, 2025 | 781,000.00 |
| Dec 31, 2024 | 52,000.00 |
| Sep 30, 2024 | 71,000.00 |
| Jun 30, 2024 | 118,000.00 |
| Mar 31, 2024 | 184,000.00 |
| Dec 31, 2023 | 244,000.00 |